Biopharma bites: Novo rebrands Rybelsus as the Ozempic pill, and Amgen trims its pipeline

FierceBiotechEdgewise data power rival to BMS and Cytokinetics toward phase 3

FierceBiotechiRhythm hit by cyberattack that compromised patient data, says operations unaffected

FierceBiotechMerck inks $510M biobucks data generation partnership with Protillion

Endpoints NewsHow to launch a telehealth business in one day

Endpoints NewsLilly buys another pain biotech; FDA sets decision for once-weekly PrEP pill

PharmaVoiceCorvus CEO thinks his next blockbuster is an ITK inhibitor

FierceBiotechAdaptive plots splitting Pfizer-partnered drug discovery unit from diagnostics business

PharmaVoiceHow Lilly is defending its GLP empire

Promega BlogThe Hidden Costs of “Good Enough” Extraction

Clinical OMICsAdaptive Deep Brain Stimulation Improves Walking and Reduces Falls in Parkinson’s Disease

FierceBiotechHow Biogen is transforming its pipeline with a VC mindset and an ‘entrepreneurial spirit’

BioWorldShenzhen Salubris Pharmaceuticals patents dual PCSK9/Lp(a)-targeting compounds